跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,225 条关于
“G12D mutation”
全部
7,225
临床试验
5,566
药物
109
机构
4
资讯
1,546
2年前
AstraZeneca Secures KRAS G12D Inhibitor in $419M Deal with Usynova
去年
KRAS Mutation Subtypes Linked to Varying Outcomes in Pancreatic Cancer
去年
RMC-9805 Demonstrates Promising Activity in KRAS G12D-Mutated Pancreatic Cancer
上个月
GenFleet's Oral KRAS G12D Inhibitor GFH375 Enters Registrational Phase III Trial in NSCLC, First of Its Kind Globally
6个月前
JingFang Medicine's GFH375 Receives China's First Breakthrough Therapy Designation for KRAS G12D-Mutated NSCLC
去年
Revolution Medicines Reports Promising Results for Zoldonrasib in KRAS G12D Mutant Lung Cancer
去年
Silexion's LODER Shows Promise in Non-Resectable Pancreatic Cancer
去年
PAQ Therapeutics Secures $39M Series B Funding and Launches Phase 1 Trial for Novel KRAS G12D Degrader
11个月前
First-in-Human Trial Shows Engineered Exosomes Safely Target KRAS G12D in Pancreatic Cancer
去年
Pancreatic Cancer Treatment Advances: New Trials and Therapies Offer Hope
第 1 页,共 155 页
上一页
下一页